soluble interleukin-5 receptor modulators(Searle)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesoluble interleukin-5 receptor modulators(Searle)
Drug Alias NameIL-5R (Searle)IL-5R
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-5 receptors modulators
TargetsInterleukin-5 receptors
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesG. D. Searle & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A